Marshall Wace, LLP Innoviva, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Innoviva, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 136,385 shares of INVA stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,385

Previous 204,752 33.39%

Holding current value

$2.43 Million

Previous $3.36 Million 21.6%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $1.12 Million - $1.37 Million	-68,367 Reduced 33.39%	136,385 $2.63 Million
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $2.63 Million - $2.99 Million	182,575 Added 823.26%	204,752 $3.36 Million
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $322,897 - $372,130	22,177 New	22,177 $337,000
Q3 2023 Nov 14, 2023	BUY	$12.37 - $13.89 $669,006 - $751,212	54,083 New	54,083 $702,000
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $3.37 Million - $3.93 Million	-285,176 Reduced 72.04%	110,691 $1.47 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $4.6 Million - $6.03 Million	395,867 New	395,867 $4.6 Million
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $544,374 - $755,738	-38,015 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $6.26 Million - $8.23 Million	-406,621 Reduced 91.45%	38,015 $736,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $571,264 - $672,160	-35,906 Reduced 7.47%	444,636 $7.67 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $1.91 Million - $2.53 Million	146,558 Added 43.88%	480,542 $8.03 Million
Q2 2021 Aug 13, 2021	BUY	$11.45 - $13.96 $3.82 Million - $4.66 Million	333,984 New	333,984 $4.48 Million
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $1.6 Million - $1.86 Million	-144,438 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $2.09 Million - $2.8 Million	-224,028 Reduced 60.8%	144,438 $1.79 Million
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $2.3 Million - $3.23 Million	222,658 Added 152.71%	368,466 $3.85 Million
Q2 2020 Aug 13, 2020	SELL	$11.49 - $15.26 $210,393 - $279,425	-18,311 Reduced 11.16%	145,808 $2.04 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $208,224 - $391,030	25,675 Added 18.55%	164,119 $1.93 Million
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $4.76 Million - $6.66 Million	-463,241 Reduced 76.99%	138,444 $1.96 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $37,426 - $54,184	-3,724 Reduced 0.62%	601,685 $6.34 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $7.35 Million - $8.39 Million	560,984 Added 1262.77%	605,409 $8.81 Million
Q1 2019 May 14, 2019	BUY	$13.69 - $20.06 $608,178 - $891,165	44,425 New	44,425 $623,000

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Innoviva, Inc. Transaction History